NATIONAL RESEARCH CORP

NATIONAL RESEARCH CORP

National Research Corporation (NRC) is a US-based provider of patient experience measurement, analytics and market intelligence for healthcare organisations. Investors should know it operates in a specialised niche: helping hospitals, clinics and payers measure satisfaction, clinical outcomes and operational performance using surveys, software and consulting services. NRC’s revenue mix tends to include subscription-style services and professional fees, which can offer recurring income but also ties performance to healthcare budgets and client retention. Growth drivers include greater emphasis on patient-centred care, digital measurement tools and value-based reimbursement, while risks include competitive pressure, regulatory change, data-security obligations and small-cap volatility. With a market capitalisation around $279m, NRC is a smaller company where liquidity and earnings variability can be greater than for large-cap peers. This summary is for educational purposes only and not personal investment advice; prospective investors should review the company’s filings, consider their own risk tolerance and, if needed, consult a qualified adviser.

Stock Performance Snapshot

Above Average

Financial Health

National Research Corp is achieving strong revenue and profits, indicating solid business performance.

Average

Dividend

National Research Corp's dividend yield of 2.64% is decent, offering a modest return for investors seeking dividends. If you invested $1000 you would be paid $26.40 a year in dividends (based on the last 12 months).

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Baskets Featuring NRC

Investing in Strong Labor Relations

Investing in Strong Labor Relations

Qantas's hefty fine for illegal layoffs highlights the severe financial risks of poor labor practices. This creates an investment opportunity in companies with strong employee relations and corporate governance, as they are better insulated from such costly disputes.

Published: August 18, 2025

Explore Basket
Riding The Regulatory Wave In Healthcare

Riding The Regulatory Wave In Healthcare

The Department of Justice's investigation into UnitedHealth's Medicare billing practices has cast a shadow over the health insurance industry, potentially leading to stricter oversight. This creates an investment opportunity in companies that provide compliance and auditing services, which are essential for navigating a more complex regulatory environment.

Published: July 25, 2025

Explore Basket

Why You’ll Want to Watch This Stock

📈

Patient Experience Focus

NRC’s core services measure patient satisfaction and outcomes — a growing priority for providers — though results can vary by contract mix and market.

🌍

Recurring Revenue Potential

Subscription-style analytics can give steady income and visibility, but performance depends on client retention and healthcare spending cycles.

Regulatory & Data Risk

Handling sensitive health data creates opportunities for value-added services but also exposes the firm to compliance, security and reputational risks.

Why invest with Nemo?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

BR

Broadridge Financial Solutions, Inc.

Broadridge Financial Solutions, Inc. is a company that provides data and analytics solutions and technology services to the financial services industry.

AER

AerCap Holdings N.V.

AerCap Holdings N.V. is an aircraft leasing company based in Ireland.

AL

Air Lease Corporation

Provides aircraft leasing and leasing related services to airlines worldwide.

Frequently asked questions